Article info
Short report
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network
- Correspondence to Professor Massimo Barberis, Clinic Unit of Histopathology and Molecular Diagnostics, Istituto Europeo di Oncologia, Milano 20141, Italy; Massimo.Barberis{at}ieo.it
Citation
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network
Publication history
- Received May 26, 2020
- Revised September 18, 2020
- Accepted September 19, 2020
- First published October 5, 2020.
Online issue publication
January 09, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.